“I take a contrarian position to views that the Internal DEP is a big flop ….” ~ @Wingmann
Literally no one on this forum has said this. So please do not put words in anyone’s mouth or infer it is the view of others on here.
What I have said, is that it’s still my opinion, and looking more likely with every subsequent update, that DEP-Docetaxel will be a dud.
Late 2018, early 2019 is when CEO Jackie Fairley said the DEP-Docetaxel Phase 2 trial would be completed.
So after 3 months of no new recruited patients, Starpharma is now commencing screening of new patients for god knows what arm of mono therapy or combination.
If only there was a way to keep shareholders fully informed. Perhaps something like a report to shareholders via the ASX 4 times a year. Like a quarterly report.
- Forums
- ASX - By Stock
- SPL
- PATIENCE
PATIENCE, page-36
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.8¢ |
Change
0.001(1.03%) |
Mkt cap ! $40.90M |
Open | High | Low | Value | Volume |
9.5¢ | 9.8¢ | 9.5¢ | $3.089K | 31.87K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 58131 | 9.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 34876 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 58131 | 0.096 |
3 | 308325 | 0.095 |
4 | 360000 | 0.094 |
2 | 9659 | 0.093 |
2 | 134306 | 0.092 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 34876 | 2 |
0.105 | 209291 | 3 |
0.110 | 168286 | 9 |
0.115 | 85453 | 2 |
0.120 | 79405 | 9 |
Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |